Copied
 
 
2022, DKK
04.07.2023
Bruttoresultat

-6.463'

Primær drift
Na.
Årets resultat

-28.463'

Aktiver

129''

Kortfristede aktiver

74.292'

Egenkapital

17.950'

Afkastningsgrad

0 %

Soliditetsgrad

14 %

Likviditetsgrad

67 %

Resultat
04.07.2023
Årsrapport
2022
04.07.2023
2021
31.05.2022
2020
01.03.2021
2019
31.08.2020
2018
22.05.2019
2017
16.05.2018
2016
26.05.2017
2015
26.05.2016
Nettoomsætning199.229152.200103.720.17596.918.90169.097.935110.574.67981.849.801
Bruttoresultat-6.463.00054.82031.0587.935.41711.351.6931.163.48114.764.13716.091.471
Resultat af primær drift023.20313.729-8.587.501106.992-15.043.519-3.975.4706.273.657
Indtægter af kapitalandele (tilknyttede og associerede) 00000000
Finansielle indtægter537.0007291.8541.014.752416.2741.585.7321.014.0921.056.386
Finansieringsomkostninger-2.048.0002.4163.278-7.467.087-2.746.832-3.103.930-920.927-202.396
Andre finansielle omkostninger00000000
Resultat før skat-30.653.00031.09210.588-11.451.534420.438-2.912.83691.4683.672.417
Resultat-28.463.00025.9868.027-8.157.372904.392720.441935.7572.084.038
Forslag til udbytte0-5.00000000-1.000.000
Aktiver
04.07.2023
Årsrapport
2022
04.07.2023
2021
31.05.2022
2020
01.03.2021
2019
31.08.2020
2018
22.05.2019
2017
16.05.2018
2016
26.05.2017
2015
26.05.2016
Kortfristede varebeholdninger55.601.00036.75224.60314.114.73713.156.8777.626.5451.798.672182.024
Kortfristede tilgodehavender fra salg og tjenesteydelser 16.679.00040.60135.83824.576.44824.694.86214.105.67820.855.65136.793.769
Likvider2.012.000142.8853.729.957107.13411.6481.563.45511.419
Kortfristede aktiver74.292.00077.36763.32642.421.14237.958.87321.743.87124.217.77836.987.212
Immaterielle aktiver og goodwill1.006.0001.7243.44600000
Finansielle anlægsaktiver44.283.00035.23125.15543.834.12035.675.44937.242.62823.295.98118.220.554
Materielle aktiver9.828.00011.3109.52513.547.49913.289.44113.584.99112.464.6773.659.228
Langfristede aktiver55.117.00048.26538.12657.381.61948.964.89050.827.61935.760.65821.879.782
Aktiver129.409.000125.632101.45299.802.76186.923.76372.571.49059.978.43658.866.994
Aktiver
04.07.2023
Passiver
04.07.2023
Årsrapport
2022
04.07.2023
2021
31.05.2022
2020
01.03.2021
2019
31.08.2020
2018
22.05.2019
2017
16.05.2018
2016
26.05.2017
2015
26.05.2016
Forslag til udbytte05.000000001.000.000
Egenkapital17.950.00060.16634.18026.152.56234.309.93433.405.54232.685.10133.154.047
Hensatte forpligtelser000000552.5761.422.530
Langfristet gæld til banker00000000
Anden langfristet gæld0000000
Leverandører af varer og tjenesteydelser7.603.00021.42014.25112.447.53214.335.1696.583.0645.901.3759.541.932
Kortfristede forpligtelser111.459.00065.46658.84462.896.38749.838.00335.055.34521.264.37624.290.417
Gældsforpligtelser111.459.00065.46667.27273.650.19952.613.82939.165.94826.740.75924.290.417
Forpligtelser111.459.00065.46667.27273.650.19952.613.82939.165.94826.740.75924.290.417
Passiver129.409.000125.632101.45299.802.76186.923.76372.571.49059.978.43658.866.994
Passiver
04.07.2023
Nøgletal
04.07.2023
Årsrapport
2022
04.07.2023
2021
31.05.2022
2020
01.03.2021
2019
31.08.2020
2018
22.05.2019
2017
16.05.2018
2016
26.05.2017
2015
26.05.2016
Afkastningsgrad Na.18,5 %13,5 %-8,6 %0,1 %-20,7 %-6,6 %10,7 %
Dækningsgrad Na.27,5 %20,4 %7,7 %11,7 %1,7 %13,4 %19,7 %
Resultatgrad Na.13,0 %5,3 %-7,9 %0,9 %1,0 %0,8 %2,5 %
Varelagerets omsætningshastighed Na.5,4 6,2 7,3 7,4 9,1 61,5 449,7
Egenkapitals-forretning -158,6 %43,2 %23,5 %-31,2 %2,6 %2,2 %2,9 %6,3 %
Payout-ratio Na.19,2 %Na.Na.Na.Na.Na.48,0 %
Gældsdæknings-nøgletal Na.-960,4 %-418,8 %-115,0 %3,9 %-484,7 %-431,7 %3.099,7 %
Soliditestgrad 13,9 %47,9 %33,7 %26,2 %39,5 %46,0 %54,5 %56,3 %
Likviditetsgrad 66,7 %118,2 %107,6 %67,4 %76,2 %62,0 %113,9 %152,3 %
Resultat
04.07.2023
Gæld
04.07.2023
Årsrapport
04.07.2023
Nyeste:01.01.2022- 31.12.2022(offentliggjort: 04.07.2023)
Information om virksomhedens regnskabsklasse:The Annual Report of OXYMAT A/S for 2022 has been prepared in accordance with the provisions of the Danish Financial Statements Act applying to enterprises of reporting class C, medium-size enterprises. The accounting policies applied are unchanged compared to last year.
Beretning
04.07.2023
Dato for ledelsens godkendelse af årsrapporten:2023-06-26
Ledelsespåtegning:Ledelsespåtegning
Beskrivelse af usædvanlige forhold, der kan have påvirket indregningen eller målingen:Unusual mattersOXYMAT A/S has identified prior period errors that work in progress has not been recognized correctly in the previous financial year, in both OXYMAT A/S and its subsidiaries. The comparative figures are corrected, because of the identified prior period errors. When comparing the comparative figures in this year’s annual report to the previous year’s annual report 2021 figures, the profit for the year has been reduced by 4,678 T. DKK. and the equity reduced by 8,752 T. DKK. Refer to the accounting policies (Note 1), where the corrected misstatement is further described.
Statement by Management on the annual report
Identifikation af den godkendte årsrapport:The Supervisory Board and the Executive Board have today considered and adopted the annual report of OXYMAT A/S for the financial year 1 January 2022 – 31 December 2022.
Management's review
Beskrivelse af virksomhedens væsentligste aktiviteter:Main activitiesOXYMAT´s main activities are development, production, and sales of on-site air separation plants for production of oxygen or nitrogen – Pressure Swing Adsorption systems (PSA). The supply of nitrogen and oxygen can be divided into four different categories: containerized gas distribution, liquid gas distribution, on-site gas production and pipe gas distribution. OXYMAT’s PSA and membrane solutions is on-site gas production. OXYMAT operates within four main markets: MARINE, MEDICAL, INDUSTRIAL and WATER. MARINEThe marine business is characterized by high barriers due to certifications. Although both oxygen and nitrogen are used on a wide range of vessel types, it is primarily on-site nitrogen production OXYMAT delivers for the marine industry. MEDICALThe medical business is also characterized by high barriers due to certifications, besides requiring high oxygen purity. All OXYMAT PSA generators can supply medical grade oxygen, and all products and production sites are medically certified. Medical customers are increasingly aware of having their own on-site oxygen production to reduce dependency on suppliers and the risk of shortage. Due to strong supply security and flexible capacity, on-site oxygen generators for medical use are increasingly considered the best alternative compared to traditional liquid supply or filled cylinders. INDUSTRIALThe industrial market includes many different applications; some within the processing industry, but also food and beverages, gold mining and oil and gas among others. While most of the other markets are either oxygen or nitrogen, the industrial segment requires both on-site oxygen as well as nitrogen. Some industries within this segment require specific certifications e. g., food and beverages, oil and gas etc. Further, for industries placed in remote off-grid areas, like the mining industry, where the only power supply is diesel generators, low energy consumption and security in supply is in high demand. WATEROXYMAT delivers on-site oxygen generators for a wide range of applications within the water industry. OXYMAT has delivered to the aquaculture industry throughout the company’s history and has a strong foothold in the segment. On-site solutions are widely used in the industry to lower production cost while at the same time getting a smaller CO₂ footprint compared to distributed gas. Oxygen supply increases fish welfare and production, and a constant flow is critical for the industry as an interruption will cause fish death. Increasing demand for high protein food such as salmon, but also limits on saltwater concessions will increase the aquaculture industry and we expect to see a rise in well boats and land-based basins – both fresh and salt water. Also, new regulations with stricter requirements for wastewater treatment for both industrial companies and sewage water are expected to drive the future market growth within oxygen for ozone treatment.